<p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 以 CCEL 为交易代码的私人脐带血银行，成功获得了细胞治疗认证基金会（FACT）对脐带血采集、储存和管理（相关和无关）捐赠的认证续期。该公司于 2014 年首次获得认证，现在又获得了三年的认证延续。续期认证将有效至 Ap。</p>

CCEL

<p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 上市的私人脐带血银行，股票代码为 CCEL，成功获得了细胞治疗认证基金会（FACT）对脐带血采集、储存和用于管理（相关和无关）捐赠的认证续期。该公司于 2014 年首次获得认证，现在又获得了三年的认证延续。续期认证将有效至四月</p>

<p>Cryo-Cell International, Inc., a private cord blood bank traded on NYSE American LLC under the symbol CCEL, has successfully obtained renewed Foundation for the Accreditation of Cellular Therapy (FACT) Accreditation for Cord Blood Collection, Banking, and Release for Administration (Related and Unrelated) Donations. Initially accredited in 2014, the company has secured another three-year accreditation extension. The renewed accreditation will remain effective until Ap.</p>
<div class="lb-trans"><p>Cryo-Cell International, Inc.是一家在 NYSE American LLC 以 CCEL 为交易代码的私人脐带血银行，成功获得了细胞治疗认证基金会（FACT）对脐带血采集、储存和管理（相关和无关）捐赠的认证续期。该公司于 2014 年首次获得认证，现在又获得了三年的认证延续。续期认证将有效至 Ap。</p>
</div>

Cryo-Cell International Receives FACT Re-accreditation, Setting the Longest Independently Validated Quality Track Record Among U.S. Private Cord Blood Banks

Cryo-Cell International 获得 FACT 重新认证，创下美国私人脐带血库中最长的独立验证质量记录